% | $
Quotes you view appear here for quick access.

RXi Pharmaceuticals Corporation Message Board

  • dctrig dctrig Apr 16, 2013 4:41 PM Flag

    CEO's Impressive Record

    Dr. Cauwenbergh served as Chairman and Chief Executive Officer of Barrier Therapeutics, Inc., a publicly-traded biopharmaceutical company he founded in 2001 that focused on dermatology drug development. Barrier was acquired by Stiefel Laboratories, Inc. in 2008. (Stiefel bought by GSK in 2009-will RXi be next?)

0.38-0.01(-2.56%)Nov 27 12:59 PMEST